Tibet Aim Pharm Inc banner

Tibet Aim Pharm Inc
SZSE:002826

Watchlist Manager
Tibet Aim Pharm Inc Logo
Tibet Aim Pharm Inc
SZSE:002826
Watchlist
Price: 21.15 CNY 0.09%
Market Cap: ¥4B

Tibet Aim Pharm Inc
Investor Relations

Tibet Aim Pharm., Inc. engages in the research and development, production, and sale of chemical drugs, and Chinese medicines. The company is headquartered in Chengdu, Sichuan and currently employs 430 full-time employees. The company went IPO on 2016-12-09. The Company’s products include self-manufacturing medicine and third-party medicine. Self-manufacturing medicine includes miglitol tablets, hongjinxiaojie tablet, aceclofenac enteric-coated tablets, montmorillonite powder, as well as domperidone tablets, among others. Its third-party medicine includes gualoupi injection, nalmefene hydrochloride injection, oral liquid for children, cefotaxime sodium for injection, as well as carbetocin injection. The firm distributes its products within domestic market and to overseas markets.

Show more
Loading
002826
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Ms. Zhou Min
GM, Financial Director & Director
No Bio Available
Ms. Qianjin Li
Deputy GM & Secretary of the Board of Directors
No Bio Available

Contacts

Address
SICHUAN
Chengdu
37F, Building B, Liangjiang International, Tianfu 1st Street
Contacts
+861058731208
www.emyy.cn
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett